Screening Intention Prediction of Colorectal Cancer among Urban Chinese Based on the Protection Motivation Theory.
colorectal cancer
knowledge
protection motivation theory
screening intention
urban Chinese
Journal
International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455
Informations de publication
Date de publication:
01 04 2022
01 04 2022
Historique:
received:
22
02
2022
revised:
30
03
2022
accepted:
30
03
2022
entrez:
12
4
2022
pubmed:
13
4
2022
medline:
14
4
2022
Statut:
epublish
Résumé
Colorectal cancer poses a serious threat worldwide. Although early screening has been proved to be the most effective way to prevent and control colorectal cancer, the current situation of colorectal cancer screening remains not optimistic. The aim of this article is to apply the protection motivation theory (PMT) to examine the influencing factors on screening intention of colorectal cancer (CRC). This cross-sectional survey was launched in five communities in Wuhan, China. All the eligible urban Chinese were recruited and interviewed using paper-and-pencil questionnaires. The intention of colorectal cancer screening (CRCS) was measured using six PMT subconstructs, including perceived risk, perceived severity, fear arousal, response efficacy, response cost, and self-efficacy. Data on sociodemographic variables and knowledge of CRC were also collected. The structural equation modeling (SEM) method was used for data analysis. Among all the 569 respondents, 83.66% expressed willingness to participate in CRCS. Data of the research fit the proposed SEM model well (Chi-square/df = 2.04, GFI = 0.93, AGFI = 0.91, CFI = 0.91, IFI = 0.91, RMSEA = 0.04). Two subconstructs of PMT (response efficacy and self-efficacy) and CRC knowledge were directly and positively associated with screening intention. Age, social status, medical history, physical activity, and CRC knowledge were indirectly related to the screening intention through at least one of the two PMT subconstructs (response efficacy and self-efficacy). The findings of this study suggest the significance of enhancing response efficacy and self-efficacy in motivating urban Chinese adults to participate in CRC screening. Knowledge of CRC is significantly associated with screening intention. This study can provide useful information for the formulation and improvement of colorectal cancer screening strategies and plans.
Identifiants
pubmed: 35409885
pii: ijerph19074203
doi: 10.3390/ijerph19074203
pmc: PMC8998218
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Références
World J Gastroenterol. 2017 May 28;23(20):3632-3642
pubmed: 28611516
BMC Public Health. 2014 Mar 07;14:238
pubmed: 24606951
Health Risk Soc. 2020;22(5-6):324-345
pubmed: 33762881
J Prev Med Public Health. 2021 Nov;54(6):431-440
pubmed: 34875826
Gut. 2019 Aug;68(8):1450-1457
pubmed: 30377193
Int J Prev Med. 2014 Feb;5(2):185-90
pubmed: 24627745
Int Q Community Health Educ. 2020 Oct;41(1):25-33
pubmed: 31876256
Psychol Health Med. 2013;18(5):522-42
pubmed: 23324044
Ethn Health. 2021 Feb;26(2):168-185
pubmed: 29973057
Prev Med. 2009 Feb;48(2):197-202
pubmed: 19073208
Chin Med J (Engl). 2021 Mar 17;134(7):783-791
pubmed: 33734139
J Intern Med. 2011 Aug;270(2):87-98
pubmed: 21575082
Pediatrics. 2009 May;123(5):e917-28
pubmed: 19380429
Clin Gastroenterol Hepatol. 2013 Feb;11(2):172-80
pubmed: 22985608
BMJ Open. 2021 Jul 12;11(7):e045168
pubmed: 34253663
J Prev Med Hyg. 2018 Jun 01;59(2):E159-E166
pubmed: 30083624
Cancer Med. 2019 Nov;8(16):7098-7107
pubmed: 31560836
Psychooncology. 2018 Feb;27(2):442-449
pubmed: 28749603
Cancer. 2007 Nov 1;110(9):2083-91
pubmed: 17893869
J Health Psychol. 2021 Sep 28;:13591053211037737
pubmed: 34581205
Health Commun. 2009 Mar;24(2):95-105
pubmed: 19280453
Rural Remote Health. 2011;11(2):1648
pubmed: 21585228
Implement Sci Commun. 2020 Jul 10;1:64
pubmed: 32885219
Am J Health Educ. 2009 Jul;40(4):220-228
pubmed: 20209024
Cancer Epidemiol Biomarkers Prev. 2005 Dec;14(12):2855-61
pubmed: 16365000
Eur J Oncol Nurs. 2016 Apr;21:17-23
pubmed: 26952674
Front Oncol. 2022 Jan 04;11:766939
pubmed: 35059311
Front Oncol. 2019 Feb 21;9:98
pubmed: 30847304
Soc Sci Med. 2015 Dec;147:113-20
pubmed: 26560410
Nat Hum Behav. 2019 May;3(5):526-536
pubmed: 30962614
CA Cancer J Clin. 2019 Nov;69(6):452-467
pubmed: 31390062
BMC Public Health. 2012 Jul 18;12:528
pubmed: 22809457
BMC Public Health. 2021 Jun 17;21(1):1165
pubmed: 34140015
Eur J Cancer Care (Engl). 2021 Mar;30(2):e13369
pubmed: 33205473
BMC Cancer. 2022 Jan 5;22(1):37
pubmed: 34983440
PLoS Negl Trop Dis. 2014 Oct 16;8(10):e3246
pubmed: 25329829
J Dig Dis. 2017 Oct;18(10):582-590
pubmed: 28945312
Prev Med. 2011 Mar-Apr;52(3-4):265-7
pubmed: 21295061
Behav Sci (Basel). 2017 Apr 14;7(2):
pubmed: 28420098
J Educ Health Promot. 2019 Sep 30;8:169
pubmed: 31867354
BMC Womens Health. 2020 Jun 11;20(1):121
pubmed: 32527329
Lancet Oncol. 2013 Apr;14(5):391-436
pubmed: 23628188
J Gastrointest Cancer. 2021 Mar;52(1):187-191
pubmed: 32125621
Prev Med Rep. 2020 Oct 06;20:101223
pubmed: 33088680
World J Gastroenterol. 2017 Jul 28;23(28):5086-5096
pubmed: 28811705
Int J Environ Res Public Health. 2020 Jul 08;17(14):
pubmed: 32650616